Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Lund, Sweden, May 16, 2013, Active Biotech (NASDAQ OMX NORDIC: ACTI) will present data from two of its oncology projects, the drug candidates tasquinimod for the treatment of prostate cancer and ANYARA for the treatment of renal cell cancer, at the scientific conference "2013 ASCO Annual Meeting" to be held in Chicago (USA) on May 31- June 4, 2013. Active Biotech's collaboration partner Ipsen will present two tasquinimod posters.
Help employers find you! Check out all the jobs and post your resume.
Lund, Sweden, May 16, 2013, Active Biotech (NASDAQ OMX NORDIC: ACTI) will present data from two of its oncology projects, the drug candidates tasquinimod for the treatment of prostate cancer and ANYARA for the treatment of renal cell cancer, at the scientific conference "2013 ASCO Annual Meeting" to be held in Chicago (USA) on May 31- June 4, 2013. Active Biotech's collaboration partner Ipsen will present two tasquinimod posters.
Help employers find you! Check out all the jobs and post your resume.
